Fire Point is funding its FP-7 and FP-9 ballistic programs with its own money; the manufacturer has not received a single hryvnia from the budget for design work. This was stated by the company's CEO Iryna Terekh, reports UNN.
According to her, the funds for development come from the profits of serial products — drones and missiles that the company already supplies to the military.
Fire Point finances the development of our ballistic program FP-7 and FP-9 exclusively with its own funds. We have not received a single hryvnia from the state for research and development work: every machine, every test bench, every test is paid for from the company's profit from serial products. As of today, we have already invested in the R&D of the missile program and continue to invest hundreds of millions of hryvnias
The state is our customer, not an investor: it buys finished products, and we have consciously taken on all the development risks
Currently, the company is working on two ballistic missiles. FP-7 — with a range of up to 300 kilometers, Fire Point calls it a cheaper response to the American ATACMS. The second, FP-9, is designed for 800-850 kilometers — enough to reach Moscow. FP-7 is already undergoing certification, and the company promises the launch of FP-9 by the end of the year.
In addition to ballistic missiles, Fire Point produces long-range drones FP-1 and FP-2, as well as the FP-5 "Flamingo" cruise missile, capable of flying three thousand kilometers. It is these serial products, the company says, that earn money for the missile program.
Using the same model, the company is also developing its largest project — the pan-European anti-ballistic shield Frejya, designed to protect the sky from ballistic threats. Fire Point is also conducting all development of "Frejya", including the interceptor missile, at its own expense. The company expects that external investment in the project will come after the first successful interceptions.
Recall
Earlier, Fire Point's chief designer and co-owner Denys Shtilerman stated that the company once received a Brave1 grant of about 700 million hryvnias, but immediately returned the funds to avoid accusations of state funding for R&D.